Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_871699
Proper Citation: Miltenyi Biotec Cat# 130-093-133, RRID:AB_871699
Target Antigen: Mouse Human CD66abce PE Clone TET2
Host Organism: mouse
Clonality: monoclonal
Comments:
Discontinued: 5-2018; manufacturer recommendations: Mouse IgG2b Immunofluorescence; Flow Cytometry; Flow cytometry; Immunofluorescence
Detection of CD66abce expression on human granulocytes, neutrophils, and some epithelial cells; detection of CD66abce expression on non-human primate granulocytes
Info: This product is discontinued and reformatted to a higher concentration for optimized use in multicolor flow cytometry panels. The replacement product cat # is 130-117-699. (RRID:AB_2733835).
We found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Mouse Anti-Human CD66abce Monoclonal Antibody, PE Conjugated Clone TET2.
Discontinued
Discontinued: 2021
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.